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History papillomavirus researcha role of human papillomaviruses (HPV) in cervical cancer has been postulated.
Today it is well established that this very heterogeneous virus family harbours important human
carcinogens, causing not only the vast majority of cervical, but also a substantial proportion of other
anogenital and head and neck cancers. In addition, speciﬁc types have been linked to certain cutaneous
cancers. In females, HPV infections on a global scale account for more than 50% of infection-linked cancers, in
males for barely 5%. Vaccines against the high risk HPV types 16 and 18 represent the ﬁrst preventive
vaccines directly developed to protect against a major human cancer (cervical carcinoma). This review will
cover some of the historical aspects of papillomavirus research; it tries brieﬂy to analyze the present state of
linking HPV to human cancers and will discuss some emerging developments.
© 2008 Elsevier Inc. All rights reserved.Early search for an infectious etiology of cervical cancer
In a now famous paper an Italian physician, Rigoni-Stern (1842),
analyzed death certiﬁcates of women in Verona during the period
1760–1839 and noted of a high frequency of cervical cancer in married
women, widows and prostitutes, but their rare occurrence in virgins
and nuns. He concluded that the development of this type of cancer
should be related to sexual contacts. The rapid development of
bacteriology in the second part of the 19th century resulted in early
attempts to link cervical cancer to sexually transmitted infectious
events, without reproducible data until the end of the 1960s. At this
time ﬁrst reports appeared incriminating a virus infection, Herpes
simplex type 2, as candidate for cervical cancer etiology (Rawls et al.,
1968; Naib et al., 1969; Nahmias et al., 1970). Although initially a
number of conﬁrmatory data have been published, a large scale
prospective study performed in former Czechoslovakia failed to
conﬁrm these results (Vonka et al. 1984a, 1984b).
In the early 1970s studies on the possible role of human
papillomaviruses (HPV) in cancers were initiated. This is discussed
subsequently.
A brief history of papillomavirus research
Skin and genital warts were well known among ancient Greek and
Romans (reviewed in Bäfverstedt, 1967). Particularly genital warts
were considered as the result of sexual promiscuity and thus, regarded
as potentially infectious. In the end of the 19th century Payne (1891)
reported the contagious rise of common warts. The ﬁrst unequivocal
demonstration of the infectious nature of human warts resulted froml rights reserved.cell-free transmission experiments of Ciuffo (1907) in Italy. This
established at the same time the viral nature of the responsible agent.
Within the 1920s the infectious nature of genital warts and laryngeal
papillomatosis was also conﬁrmed (see review Syrjänen and Syrjänen,
2008). Electron microscopic demonstration of viral particles was
achieved in 1949 (Strauss et al., 1949).
Although important developments, demonstrating for the ﬁrst
time the carcinogenic potential of rabbit papillomaviruses in cotton-
tail and domestic rabbits (Rous and Beard, 1934; Rous and Kidd, 1938;
Rous and Friedewald, 1944), followed in the 1930s, in these years
interest in humanwart virus remained low. Nevertheless, in particular
molecular studies on bovine papillomaviruses (Heilman et al., 1980;
Engel et al., 1983) turned out to be helpful for subsequent analyses of
HPV types. In 1965 ﬁrst reports appeared characterizing the double-
stranded circular DNA of human papillomavirus (Crawford, 1965; Klug
and Finch, 1965). In a stimulating review in 1967, Rowson and Mahy
(1967) still describe the various forms of warts and papillomas caused
by the human wart virus. The history of epidermodysplasia verruci-
formis will be brieﬂy discussed in a subsequent chapter.
In the 1970s the plurality of human papillomavirus types became
apparent. An early suggestion for antigenic differences between
cutaneous and genital wart papillomavirus particles originated from
electron microscopic analysis of particle agglutination studies
(Almeida et al., 1969). Antisera to skin wart virus reacted with both,
skin and genital wart viruses, whereas antisera to genital wart virus
reacted only with the genital wart virus particles (Almeida et al. 1969).
This study has not been reproduced; the basis for this observation is
still not understood.
A clear hint for the heterogeneity of the human papillomavirus
family originated from hybridization studies with in vitro transcribed
plantar papillomavirus RNA and DNA from various cutaneous, genital
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Although in part papillomavirus particle-positive, only a limited
number of DNAs from cutaneous warts and none of the DNAs from
genital warts reacted with the plantar virus RNA probe. Subsequent
studies revealing the intratypic heterogeneity of plantar wart virus
preparations (Gissmann and zur Hausen, 1976) and type-speciﬁc
endonuclease restriction patterns of various isolates (Gissmann et al.,
1977; Orth et al., 1977) clearly established the plurality of human
papillomavirus types.
This review concentrates on the present role of HPV types in
human cancers, by stressing some of the historical developments. It is
not intended to review a large number of epidemiological or
seroepidemiological data, including additional risk factors, obtained
mainly during the past two decades.
Papillomaviruses and cervical cancer
Experiments trying to establish a relationship between papillo-
mavirus infections and cervical cancer were initiated in 1972. They
were based on anecdotal reports in the medical literature of rare
malignant conversion of genital warts (condylomata acuminata) into
squamous cell carcinomas (reviewed in zur Hausen,1977), resulting in
the hypothesis that cervical cancer may arise from infections with the
virus found in condylomata acuminata (zur Hausen 1974, 1975, 1976).
The speculation appeared to be boosted by negative attempts to
demonstrate herpes simplex type 2 DNA in cervical cancer biopsies
(zur Hausen et al., 1974b). The isolation of novel HPV types from
genital warts, HPV 6, (Gissmann and zur Hausen, 1980; de Villiers et
al., 1981) and laryngeal papillomas, HPV 11, (Gissmann et al. 1982a,b)
permitted direct approaches to answer this question.
In 1976 (Meisels and Fortin, 1976) and 1977 (Meisels et al., 1977),
Meisels and Fortin postulated that koilocytotic cells found in cervical
smears of patients with ﬂat dysplastic lesions represent the
cytopathogenic change of a papillomavirus infection. Initially these
authors hypothesized that the discovery of such koilocytotic cells
permitted a differentiation between the koilocyte-positive “benign”
proliferations from koilocyte-negative lesions, assumed to represent
“truly premalignant” cells. The demonstration of typical papilloma-
virus particles within koilocytotic cells by Della Torre et al. (1978) and
by Hills and Laverty (1979) conﬁrmed the HPV-mediated cytopathic
effect as proposed by Meisels and Fortin.
In 1982 the ﬁrst three reports on HPV sequences in human tumors
were published. Early in 1982, Gissmann et al. (1982a,b) reported HPV
6 DNA in biopsies from three invasively growing giant condylomata
acuminata (Buschke–Löwenstein tumors). This was conﬁrmed in
December of the same year by Zachow et al. (1982) in a series of
additional Buschke–Löwenstein tumors. The result was not particu-
larly surprising, since these invasively growing but commonly non-
metastasizing tumors originate from typical genital warts. In a third
report by Green et al. (1982) epidermodysplasia verruciformis HPV-
related bands were demonstrated in some cervical cancer biopsies.
According to the cleavage pattern they were likely to represent HPV
10. This type and other epidermodysplasia verruciformis HPV-related
viruses have subsequently not been identiﬁed in cervical cancer
biopsies.
Southern blot hybridizations with HPV 11 DNA permitted the
detection of this DNA in one out of 24 cervical carcinoma biopsies
(Gissmann et al., 1983). By using HPV 11 as probe, it was possible to
isolate a novel HPV DNA directly from cervical cancer biopsies,
subsequently labelled as HPV 16 (Dürst et al., 1983). Shortly thereafter,
the same group isolated and partially characterized HPV 18 DNA from
cervical cancer biopsies as well as from several cervical cancer derived
cell lines (among them HeLa cells) (Boshart et al., 1984). Within the
same year it was possible to demonstrate HPV 16 DNA in typical
precursor lesions of anogenital cancers, Bowenoid papulosis (Ikenberg
et al., 1983) and 1 year later in cervical intraepithelial neoplasias(Crum et al. 1984). Without reviewing here the subsequent burst of
molecular and epidemiological data within the following years,
among others a few major steps deserve mentioning. Early in 1985
the selective transcription of E6 and E7 genes in cervical cancer and
speciﬁc deletions occurring in the course of integration of viral DNA
into host cell DNA were established (Schwarz et al., 1985). Within the
same year this was conﬁrmed by another group (Yee et al., 1985). The
interaction of E6 protein with p53, resulting in degradation of this
protein (Werness et al., 1990), and of E7 with pRb, blocking the
function of the latter (Dyson et al., 1992), were important for the
initiation and understanding of intracellular events resulting in
immortalization and eventually in a transformed phenotype of the
viral genome harbouring cells. Cell transformation by these viral
oncogenes was initially shown for rodent cells (Yasumoto et al., 1986)
and shortly thereafter also for human keratinocytes (Dürst et al., 1987;
Pirisi et al., 1987). In addition, induction of tumors in transgenic
animals (Lambert et al., 1993; Arbeit et al., 1993) clearly demonstrated
the oncogenic potential of these genes. Global epidemiological studies
identiﬁed HPV 16, 18 and a few others as major risk factors for cervical
cancer (Muñoz et al., 1992; Bosch et al., 1992). The interruption of
intra- and extracellularly triggered pathways as a precondition for
malignant conversion (zur Hausen and Rösl,1994; Soto et al., 2000), as
well as the essential role of viral oncoprotein expression for the
maintenance of the malignant phenotype (Storey et al., 1991; von
Knebel Doeberitz et al., 1992, 1994), the serology of HPV infections
(Stanley et al., 1994; Strickler et al., 1994), and the recent development
of HPV vaccines have been covered in several reviews (e.g. zur Hausen,
1996; Schiller and Lowy, 2006; Frazer, 2007).
Today it is verywell established that infectionwith speciﬁc types of
HPV can cause cervical cancer. The interventionwith vaccines permits
already today the statement that essential precursor lesions of this
cancer are efﬁciently prevented. Although more than 95% of cervical
cancer biopsies contain high risk HPV genomes, this ﬁgure does not
necessarily imply that all of these tumors are caused by these
infections. Long-term follow-up studies of vaccinated women,
particularly after achieving a broad protection against the majority
of high risk HPV types, will provide a better basis for more accurate
estimates. Cervical cancer, on the global scale, represents the second
most frequent cancer in women. Thus, speciﬁc HPV types emerge as
one of the most important infectious carcinogens in humans.
Papillomaviruses and anogenital cancers
Verrucous carcinomas of the vulva and the penis may occasionally
develop in persisting genital warts and frequently do contain HPV 6 or
11 DNA (Gissmann et al., 1982a,b; Zachow et al., 1982; Boshart and zur
Hausen, 1986). Soon after the discovery of HPV 16 and 18 in cervical
cancer biopsies, the same as well as additional HPV types were also
found in other anogenital cancers. Early studies revealed already that
Bowenoid papulosis of vulva and penis, as precursor lesions of cancers
at external genital sites, were frequently positive for HPV 16 DNA
(Ikenberg et al 1983). It is presently well established that only
approximately 50% of vulvar squamous cell carcinomas are HPV-
positive, mainly containing HPV 16 DNA (Madsen et al., 2008).
Similarly, only 30–50% of penile carcinomas contain HPV DNA (Rubin
et al., 2001; Bezerra et al., 2001; Lont et al., 2006). In general, HPV-
positive vulva and penile carcinomas seem to have a better prognosis
in comparisonwith the negative tumors (Lont et al., 2006). Sincemany
of the epidemiological risk factors for penile and vulva cancers
resemble those established for cervical cancer (Hildesheim et al., 1997;
Dillner et al., 2000; Rubin et al., 2001; Madsen et al., 2008), causal
events leading to HPV-negative tumors at these sites represent an
important open question. Different infectious causes of these cancers
remain an interesting speculation.
In contrast to penile and vulva cancers, carcinomas of the vagina
are in the range 60–90% HPV positive (IARC, 1995; Madsen et al.,
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et al., 1999) The global incidence of anal and perianal cancers is
relatively low, ranging between 0.1 to 2.8 cases per 100,000 (WHOCT,
2000). Sexual habits, men having sex with men (MSM), lead to a
dramatically increased risk to an estimated incidence rate of 35 per
100,000 that may go up to 70 per 100,000 among HIV-seropositive
MSM (Daling et al., 1987). Early demonstration of HPV 16 in anal
carcinomas dates back to 1986 (Scheurlen et al. 1986; Hill and Coghill,
1986). In the same year a report described the frequent occurrence of
anal intraepithelial dysplastic lesions in homosexual men (Nash et al.,
1986).
Papillomaviruses and head and neck cancers
A number of early reports discussed the malignant conversion of
recurrent laryngeal papillomas into squamous cell carcinomas, dating
back in part to the 1940s and 1950s (reviewed in zur Hausen 1977).
Interestingly, an early report also claimed a 5–6 fold increased risk of
women with cervical cancer for the subsequent development of oral
cancer (Newell et al., 1975). Syrjänen and colleagues (1983) reported
positive immunoperoxidase staining with anti-HPV serum in oral
focal epithelial hyperplasia and oral squamous cell papillomas. The
demonstration of papillomavirus antigens in premalignant lesions of
the oropharynx provided ﬁrst hints for a possible role of papilloma-
virus infections in oral squamous cell carcinomas (Syrjänen et al.,
1983). The ﬁrst unequivocal reports of speciﬁc HPV types in tongue
and other oropharyngeal carcinomas appeared in 1985 (Löning et al.,
1085; de Villiers et al., 1985). Three of 13 carcinomas tested contained
HPV 16 DNA, one was HPV 11 positive, and one contained HPV 27 DNA
(initially labelled as variant HPV 2). In subsequent years a large
number of studies conﬁrmed these data, although the rate of positivity
varied commonly between 25 and 60% (Weinberger et al., 2006; Psyrri
and DiMaio, 2008; Gillison et al., 2008). In a more detailed analysis
Weinberger et al. (2006) demonstrated that out of 61% of HPV 16-
positive oropharyngeal carcinomas 23% revealed a similar expression
pattern of p16 as observed in cervical cancers. This raises the question
whether some of the other HPV-positive tumors may have originated
from the contamination of the tumor tissue with HPV 16 from virus-
production at other non-malignant oropharyngeal sites of the same
patient. This point requires further investigations. A conservative
estimate of 25–30% of oropharyngeal cancers probably caused by high
risk HPVs may be closer to reality.
A few aspects are interesting to note: according to the SEER
statistics, in the USA the annual incidence of base-tongue and tonsil
cancers among white men and women aged 20–44 years increased
between 1973 and 2001 by 2.1 and 3.9%, respectively (Shiboski et al.,
2005). Sexual practices seem to be partially responsible for the
acquisition of anogenital HPV infections in the oral cavity (Schwartz et
al., 1998; D'Souza et al., 2007). Patients with anogenital cancers had a
4.3-fold increased risk of tonsillar cancers (Frisch and Biggar, 1999). In
tonsillar cancer a particularly high rate of HPV positivity had been
noted, accompanied by E6 and E7 gene expression (Snijders et al.,
1992). A better prognosis has been reported for HPV positive in
comparison to HPV-negative oral squamous cell carcinomas HPV-
linked oropharyngeal cancers, with a 60–80% reduction in risk of
death (Psyrri and DiMaio, 2008).
In summary, approximately on quarter to one third of orophar-
yngeal cancers are probably caused by anogenital high risk HPV
infections.
A low number of verrucous carcinomas of the larynx may develop
after prolonged episodes of recurrent papillomatosis (Abramson et al.,
1985; Brandsma et al., 1986), occasionally also within the bronchial
tract (reviewed in zur Hausen 1974). They contain HPV 16, HPV 11 or
HPV 6 DNA (reviewed in Steinberg,1990). First reports on HPV types in
spontaneously arising laryngeal cancers (HPV 16 and HPV 30)
appeared in 1986 (Kahn et al., 1986; Scheurlen et al., 1986). It seemstoday that the vast majority of laryngeal carcinomas are negative for
established HPV types and that the percentage of positive cancers at
this site does not exceed 5%.
Papillomaviruses and skin cancers
Although not recognized at that time, the history of papillomavirus
infections and cancer of the skin dates back to the year 1922, when
Lewandowsky and Lutz (1922) described a rare hereditary condition,
epidermodysplasia verruciformis. Particularly at light-exposed sites,
large areas of the skin are covered by ﬂat papillomatous lesions, some
of which may convert into squamous cell carcinomas after one or two
decades of persistence. Within the 1960s typical papillomavirus
particles have been detected electron microscopically within the
papillomatous lesions, but not in malignant tissue (Ruiter and Van
Mullem,1970; Yabe et al., 1969). Even prior to their demonstration, the
infectious nature of these lesions was shown in auto- and hetero-
inoculation experiments, where cell-free extracts resulted in the
induction of ﬂat warts (Lutz, 1946; Jablonska and Millewski, 1957;
Jablonska and Formas, 1959).
In 1978, Orth et al. (1978) reported the presence of speciﬁc HPV
types in malignant lesions of epidermodysplasia patients HPV 5 and
to a lesser extent a related virus, HPV 8, and HPVs 12, 14, 17, or 20 are
found in malignant lesions (reviewed in Orth, 1986). Experimental
data support a role of these viruses in the conversion of skin cells
towards malignant growth. This is in particular supported by the
development of skin tumors in mice transgenic for early genes of HPV
8 (Schaper et al., 2005) and HPV 20 (Michel et al., 2006). Relatively
little is known on transcription and expression of viral early genes
within human malignant lesions. No cell cultures have yet been
established from Epidermodysplasia verruciformis (EV) lesions. EV
represents a rare, autosomal recessive dermatosis, commonly
accompanied by inactivating mutations in the related EVER1/TMC6
and EVER2/TMC8 genes (reviewed in Orth, 2008). Thus, in spite of the
regular presence of speciﬁc HPV types in the malignant lesions of EV
patients and a larger number of experimental data on HPV 5, 8 and
20 gene functions, too few studies exist analyzing directly the
malignant tumors. The interaction of these viruses with UV light,
studied for HPV 20 (Ruhland and de Villiers, 2001) should require
further attention.
Warts and squamous cell carcinomas (SSC) of the skin arise as a
frequent complication in organ transplant recipients (reviewed in
Bouwes Bavinck et al., 2001). Although studied for more than
2 decades, the role of HPV types in SSC induction remains unclear.
This is in part due to the diverse group of HPV types found in these
lesions, but also in normal skin, and the presence of multiple types
within the same biopsy and or skin abrasion. An initial report
described the presence of HPV 5 DNA in skin cancers of an
immunosuppressed renal allograft recipient (Lutzner et al., 1983),
followed by two reports in 1994 of a high rate of HPV positivity (40–
56%) in SSCs of immunosuppressed patients (Stark et al., 1994;
Shamanin et al., 1994). In the following years the plurality of HPV
types in these cancers was conﬁrmed, the low copy number of far less
than 1 genome copy per tumor cell and the high rate of positive data
from normal skin materials and plucked hair render an interpretation
of these data difﬁcult. A possible indirect function of the infecting HPV
types in skin carcinogenesis may originate from observations
demonstrating the inhibition of apoptosis by E6 of some cutaneous
HPV types (Jackson et al., 2000) and the degradation of E6 of HPV 20
by p53 (Fei and de Villiers, 2008). The latter observation contrasts data
obtained for high risk anogenital HPVs and could provide a reasonable
explanation for syncarcinogenic effects of HPV infections and sun-
light exposure. p53 mutations induced by the UV part of sunlight (see
review de Gruijl and Rebel, 2008) would permit an unimpaired
expression of viral oncoproteins. This, however, requires further
investigations.
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is not yet resolved.
Other cancers linked to papillomavirus infections
A number of individual reports claim mainly the presence of
anogenital human papillomavirus types in cancers of the esophagus,
prostate, bladder, breast, lung and other organ sites (see review IARC,
Human Papillomaviruses, Volume 90, 2008). With the exception of
nail bed cancers, none of these reports demonstrated a consistent
association of these viruses with cancer of the respective sites.
Although it is likely that high risk HPV types may occasionally cause
cancers in atypical locations, the inconsistency of these reports does
not warrant an intensive discussion in this review.
It should be noted, however, that most present searches for novel
HPV rest on the use of established consensus primers in polymerase
chain reactions, permitting to some degree the detection of only
partially homologous sequences. Theoretically, HPV types not dis-
covered by these primers and very distantly related to known type of
this virus group would in all likelihood escape detection. An
interesting example of a very novel virus type, apparently represent-
ing a kind of chimera between late papillomavirus sequences and an
early region organization of a typical polyoma-type virus has recently
isolated from skin lesions of an Australian marsupial, the bandicoot
(Woolford et al., 2007; Bennett et al., 2008). Its sequence relationship
to knownmembers of either of the two virus families is lowandwould
not permit their discovery by using consensus primers presently
developed for known HPV or polyoma-type viruses. The identiﬁcation
of such agents would be particularly difﬁcult if they originate from
another species, are for instance replication-defective in human cells,
but still could express early functions that in a speciﬁcally “condi-
tioned” cell may lead tomalignant transformation (zur Hausen, 2008).
The recent isolation of a novel polyoma-type virus fromMerkel cell
carcinomas (Feng et al., 2008) in the future may draw more attention
to this structurally related virus family. There are still a large number
of skin cancers, vulva and penile cancers negative for identiﬁed HPV
types. The incidence of all of these cancers is substantially increased
under long-term immunosuppression (Vajdic et al., 2006) which may
hint to a possible infectious etiology of these lesions.
Conclusions
Although the history of papillomavirus research reaches far back to
the beginning of the last century, only advances made in the 1970s
permitted an analysis of the plurality of HPV types and the establish-
ment of a role of speciﬁc types in cervical cancer. Additional evidence
today stresses a role of the same types in anal cancer, in up to 50% of
other anogenital cancers, and in 25 to 30% of head and neck cancers.
The role of HPV in squamous cell carcinomas of the skin is less well
established, even though a rare hereditary condition with malignant
conversion of papillomatous lesions at sun-exposed sites, epidermo-
dysplasia verruciformis, has been linked to infections with additional
HPV types. Thus, members of the papillomavirus family turn out to be
particularly important human carcinogens.
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